Article
Niclosamide Prodrug Enhances Oral Bioavailability and Efficacy Against Hepatocellular Carcinoma by Targeting Vasorin-TGFβ Signaling
2025-03-05
Abstract excerpt
<h4>Background: </h4> Hepatocellular carcinoma (HCC) ranks third in cancer-related deaths worldwide, with limited therapeutic options. While niclosamide (NIC) has shown potential for repurposing in HCC, its poor water solubility and low bioavailability limit its efficacy, and its mechanisms of action are not yet fully elucidated. <h4>Methods:</h4> We designed a water-soluble NIC prodrug (NIC-PS) and evaluated its...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 9c19cd7a-a731-55be-855f-2e00fbf3db20
- DOI
- 10.22541/au.174119415.55528730/v1
